Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin - No Study Results Posted

Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin (ECGPPA)

This study has been completed.

Study NCT00973986 Information provided by Liuhuaqiao Hospital

First Received: September 4, 2009 Last Updated: November 28, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2011
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)